New tentative approval for Alembic drug dabigatran etexilate mesylate

Fecha de publicación: 15/07/2024
Fuente: Biotechblog
Lugar: Tentative Approval
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
Source